The evolution of selective estrogen receptor modulators in osteoporosis therapy

Selective estrogen receptor modulators (SERMs), which exhibit estrogen receptor agonist or antagonist activity based on the target tissue, have evolved through multiple generations for the prevention and/or treatment of postmenopausal osteoporosis. An ideal SERM would protect bone without stimulatin...

Descripción completa

Detalles Bibliográficos
Autor principal: Hadji, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2012
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793274/
https://www.ncbi.nlm.nih.gov/pubmed/22853318
http://dx.doi.org/10.3109/13697137.2012.688079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793274/
https://www.ncbi.nlm.nih.gov/pubmed/22853318
http://dx.doi.org/10.3109/13697137.2012.688079

Ejemplares similares